Company Fundamentals\Company Profile
A Wright Investors' Service Research Report:
Regen Biologics, Inc.
440 Wheelers Farms Road
Milford, CT 06461 U.S.A.
Figures in U.S. Dollars
Wright Quality Rating:LLNN Key Data
ReGen Biologics, Inc. (ReGen) is a development stage orthopedic products company Ticker:
that develops, manufactures and markets tissue growth and repair products for RGBO
United States and global markets. The Company's collagen matrix technology
includes applications in orthopedics, general surgery, spine, cardiovascular and drug 2008 Sales:
delivery. Some of these applications are marketable while others are in various
stages of development. ReGen's first approved product using its collagen matrix
technology is the Menaflex collagen meniscus implant device (also known as the
CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, Major Industry:
and the Republic of South Africa, through the Company's subsidiary, ReGen Biologics Drugs, Cosmetics & Health
Stock Chart Officers
Chairman, President, Chief Sub Industry:
Executive & Chief Financial Medical, Surgical & Dental
Dr. Gerald E. Bisbee Jr.
Fiscal Year Ends:
Stock Price (12/17/2010): 0.03